Clinical Trials Directory

Trials / Completed

CompletedNCT01607853

A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris

A Phase IIa Exploratory Study Evaluating the Anti-psoriatic Effect of Daivobet® Gel Applied Then Removed After 10 Minutes, Daivobet® Gel Applied Then Removed After 20 Minutes, Daivobet® Gel Applied for 24 Hours and Daivobet® Gel Vehicle Applied for 24 Hours

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
24 (actual)
Sponsor
LEO Pharma · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the anti-psoriatic effect of Daivobet® gel applied then removed after 10 minutes (+/- 2 minutes), Daivobet® gel applied then removed after 20 minutes (+/- 2 minutes) compared with Daivobet® gel and Daivobet® gel vehicle applied for 24 hours (+/- 2 hours), using the psoriasis plaque test modified from the method developed by KJ Dumas and JR Scholtz.

Conditions

Interventions

TypeNameDescription
DRUGDaivobet® gel applied then removed after 10 minutes (+/- 2 minutes)Once daily application, 3 weeks
DRUGDaivobet® gel applied then removed after 20 minutes (+/- 2 minutes)Once daily application, 3 weeks
DRUGDaivobet® gel applied for 24 hours (+/- 2 hours)Once daily application, 3 weeks
DRUGDaivobet® gel vehicle applied for 24 hours (+/- 2 hours)Once daily application, 3 weeks

Timeline

Start date
2012-06-01
Primary completion
2012-10-01
Completion
2012-10-01
First posted
2012-05-30
Last updated
2025-03-10
Results posted
2013-12-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01607853. Inclusion in this directory is not an endorsement.